Literature DB >> 26400401

Dynamics of Immune Cell Types Within the Macaque Corpus Luteum During the Menstrual Cycle: Role of Progesterone.

Cecily V Bishop1, Fuhua Xu2, Theodore A Molskness2, Richard L Stouffer3, Jon D Hennebold3.   

Abstract

The goal of the current study was to characterize the immune cell types within the primate corpus luteum (CL). Luteal tissue was collected from rhesus females at discrete intervals during the luteal phase of the natural menstrual cycle. Dispersed cells were incubated with fluorescently labeled antibodies specific for the immune cell surface proteins CD11b (neutrophils and monocytes/macrophages), CD14 (monocytes/macrophages), CD16 (natural killer [NK] cells), CD20 (B-lymphocytes), and CD3epsilon (T-lymphocytes) for analysis by flow cytometry. Numbers of CD11b-positive (CD11b(+)) and CD14(+) cells increased significantly 3 to 4 days after serum progesterone (P4) concentrations declined below 0.3 ng/ml. CD16(+) cells were the most abundant immune cell type in CL during the mid and mid-late luteal phases and were 3-fold increased 3 to 4 days after serum P4 decreased to baseline levels. CD3epsilon(+) cells tended to increase 3 to 4 days after P4 decline. To determine whether immune cells were upregulated by the loss of luteotropic (LH) support or through loss of LH-dependent steroid milieu, monkeys were assigned to 4 groups: control (no treatment), the GnRH antagonist Antide, Antide plus synthetic progestin (R5020), or Antide plus the estrogen receptor agonists diarylpropionitrile (DPN)/propyl-pyrazole-triol (PPT) during the mid-late luteal phase. Antide treatment increased the numbers of CD11b(+) and CD14(+) cells, whereas progestin, but not estrogen, replacement suppressed the numbers of CD11b(+), CD14(+), and CD16(+) cells. Neither Antide nor steroid replacement altered numbers of CD3epsilon(+) cells. These data suggest that increased numbers of innate immune cells in primate CL after P4 synthesis declines play a role in onset of structural regression of primate CL.
© 2015 by the Society for the Study of Reproduction, Inc.

Entities:  

Keywords:  corpus luteum; luteal regression; macrophage; natural killer cell; neutrophil; primate

Mesh:

Substances:

Year:  2015        PMID: 26400401      PMCID: PMC5333802          DOI: 10.1095/biolreprod.115.132753

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  63 in total

1.  Microarray analysis of the primate luteal transcriptome during chorionic gonadotrophin administration simulating early pregnancy.

Authors:  C V Bishop; S Satterwhite; L Xu; J D Hennebold; R L Stouffer
Journal:  Mol Hum Reprod       Date:  2011-11-09       Impact factor: 4.025

Review 2.  The origin and function of tumor-associated macrophages.

Authors:  A Mantovani; B Bottazzi; F Colotta; S Sozzani; L Ruco
Journal:  Immunol Today       Date:  1992-07

3.  Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice.

Authors:  Guanping Mao; Junpeng Wang; Youmin Kang; Ping Tai; Jing Wen; Qiang Zou; Ge Li; Hong Ouyang; Guoliang Xia; Bin Wang
Journal:  Endocrinology       Date:  2010-09-15       Impact factor: 4.736

4.  Dynamic changes in gene expression that occur during the period of spontaneous functional regression in the rhesus macaque corpus luteum.

Authors:  Randy L Bogan; Melinda J Murphy; Jon D Hennebold
Journal:  Endocrinology       Date:  2008-10-23       Impact factor: 4.736

5.  Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1.

Authors:  Jianru Wang; Ye Tian; Kate L E Phillips; Neil Chiverton; Gail Haddock; Rowena A Bunning; Alison K Cross; Irving M Shapiro; Christine L Le Maitre; Makarand V Risbud
Journal:  Arthritis Rheum       Date:  2013-03

Review 6.  Monocyte chemoattractant protein 1 in luteolysis.

Authors:  L A Penny
Journal:  Rev Reprod       Date:  2000-05

7.  Progesterone production by monkey luteal cell subpopulations at different stages of the menstrual cycle: changes in agonist responsiveness.

Authors:  J D Brannian; R L Stouffer
Journal:  Biol Reprod       Date:  1991-01       Impact factor: 4.285

8.  Distribution of leukocyte subpopulations in the human corpus luteum.

Authors:  L J Wang; V Pascoe; O M Petrucco; R J Norman
Journal:  Hum Reprod       Date:  1992-02       Impact factor: 6.918

Review 9.  CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges.

Authors:  Gemma E White; Asif J Iqbal; David R Greaves
Journal:  Pharmacol Rev       Date:  2013-01-08       Impact factor: 25.468

10.  Regulated C-C motif ligand 2 (CCL2) in luteal cells contributes to macrophage infiltration into the human corpus luteum during luteolysis.

Authors:  Junko Nio-Kobayashi; Masataka Kudo; Noriaki Sakuragi; Shunsuke Kimura; Toshihiko Iwanaga; W Colin Duncan
Journal:  Mol Hum Reprod       Date:  2015-05-23       Impact factor: 4.025

View more
  4 in total

1.  Changes in immune cell distribution and their cytokine/chemokine production during regression of the rhesus macaque corpus luteum.

Authors:  Cecily V Bishop; Fuhua Xu; Rosemary Steinbach; Ellie Ficco; Jeffrey Hyzer; Steven Blue; Richard L Stouffer; Jon D Hennebold
Journal:  Biol Reprod       Date:  2017-06-01       Impact factor: 4.285

Review 2.  Ovulation: Parallels With Inflammatory Processes.

Authors:  Diane M Duffy; CheMyong Ko; Misung Jo; Mats Brannstrom; Thomas E Curry
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

3.  Primary replication and invasion of the bovine gammaherpesvirus BoHV-4 in the genital mucosae.

Authors:  Bo Yang; Yewei Li; Osvaldo Bogado Pascottini; Jiexiong Xie; Ruifang Wei; Geert Opsomer; Hans Nauwynck
Journal:  Vet Res       Date:  2017-11-28       Impact factor: 3.683

4.  Parity-Dependent Hemosiderin and Lipofuscin Accumulation in the Reproductively Aged Mouse Ovary.

Authors:  Ulises Urzua; Carlos Chacon; Renato Espinoza; Sebastián Martínez; Nicole Hernandez
Journal:  Anal Cell Pathol (Amst)       Date:  2018-03-15       Impact factor: 2.916

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.